NASDAQ
EMBC

Embecta Corp

Medical Instruments & Supplies
Healthcare

Prices are adjusted according to historical splits.

Embecta Corp Stock Price

Vitals

Today's Low:
$16.23
Today's High:
$16.94
Open Price:
$16.34
52W Low:
$22.0769
52W High:
$36.0628
Prev. Close:
$16.17
Volume:
585408

Company Statistics

Market Cap.:
$1.50 billion
Book Value:
-14.359
Revenue TTM:
$1.12 billion
Operating Margin TTM:
28.35%
Gross Profit TTM:
$774.90 million
Profit Margin:
8.44%
Return on Assets TTM:
19.4%
Return on Equity TTM:
0%

Company Profile

Embecta Corp had its IPO on 2022-04-01 under the ticker symbol EMBC.

The company operates in the Healthcare sector and Medical Instruments & Supplies industry. Embecta Corp has a staff strength of 2,000 employees.

Stock update

Shares of Embecta Corp opened at $16.34 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $16.23 - $16.94, and closed at $16.71.

This is a +3.34% increase from the previous day's closing price.

A total volume of 585,408 shares were traded at the close of the day’s session.

In the last one week, shares of Embecta Corp have slipped by -8.39%.

Embecta Corp's Key Ratios

Embecta Corp has a market cap of $1.50 billion, indicating a price to book ratio of 2.6134 and a price to sales ratio of 1.6539.

In the last 12-months Embecta Corp’s revenue was $1.12 billion with a gross profit of $774.90 million and an EBITDA of $348.90 million. The EBITDA ratio measures Embecta Corp's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Embecta Corp’s operating margin was 28.35% while its return on assets stood at 19.4% with a return of equity of 0%.

In Q1, Embecta Corp’s quarterly earnings growth was a negative -82.6% while revenue growth was a positive 0.9%.

Embecta Corp’s PE and PEG Ratio

Forward PE
0
Trailing PE
15.8848
PEG

Its diluted EPS in the last 12-months stands at $1.65 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Embecta Corp’s profitability.

Embecta Corp stock is trading at a EV to sales ratio of 2.93 and a EV to EBITDA ratio of 7.4434. Its price to sales ratio in the trailing 12-months stood at 1.6539.

Embecta Corp stock pays annual dividends of $0.45 per share, indicating a yield of 2.29% and a payout ratio of 16.3%.

Balance sheet and cash flow metrics

Total Assets
$1.21 billion
Total Liabilities
$357.70 million
Operating Cash Flow
$-5800000.00
Capital Expenditure
$5.80 million
Dividend Payout Ratio
16.3%

Embecta Corp ended 2024 with $1.21 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $1.21 billion while shareholder equity stood at $-822600000.00.

Embecta Corp ended 2024 with $46.90 million in deferred long-term liabilities, $357.70 million in other current liabilities, 600000.00 in common stock, $-545100000.00 in retained earnings and $15.70 million in goodwill. Its cash balance stood at $346.40 million and cash and short-term investments were $346.40 million. The company’s total short-term debt was $13,100,000 while long-term debt stood at $1.60 billion.

Embecta Corp’s total current assets stands at $756.30 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $152.70 million compared to accounts payable of $52.50 million and inventory worth $157.60 million.

In 2024, Embecta Corp's operating cash flow was $-5800000.00 while its capital expenditure stood at $5.80 million.

Comparatively, Embecta Corp paid $0.16 in dividends in 2024.

Other key metrics

Current Trading Price
$16.71
52-Week High
$36.0628
52-Week Low
$22.0769
Analyst Target Price
$27

Embecta Corp stock is currently trading at $16.71 per share. It touched a 52-week high of $36.0628 and a 52-week low of $36.0628. Analysts tracking the stock have a 12-month average target price of $27.

Its 50-day moving average was $19.42 and 200-day moving average was $25.82 The short ratio stood at 11.08 indicating a short percent outstanding of 0%.

Around 55.4% of the company’s stock are held by insiders while 10008.4% are held by institutions.

Frequently Asked Questions About Embecta Corp

The stock symbol (also called stock or share ticker) of Embecta Corp is EMBC

The IPO of Embecta Corp took place on 2022-04-01

Similar Industry Stocks (Medical Instruments & Supplies)

Last Price
Chg
Chg%
$10502.8
-32.1
-0.3%
$143.25
-4.95
-3.34%
$4.69
-0.07
-1.47%
$42.74
-0.02
-0.05%
$10.99
0.36
+3.39%
$181.88
0.84
+0.46%
$0.09
0.04
+93.13%
$0.03
-0
-10.32%
$15.56
0.06
+0.4%
$38.63
-1.69
-4.19%

Most Active

Last Price
Chg
Chg%
Amyris Inc (AMRS)
$0.14
0.07
+100%
$0.12
0.04
+45.29%
$0.96
0.05
+5.4%
$1.34
-0.35
-20.71%
Humbl Inc (HMBL)
$0
0
0%

Top Gainers

Last Price
Chg
Chg%
$0
0
+172200%
$0
0
+51200%
$283
280.03
+9428.62%
$11.2
10.57
+1667.68%
Latch Inc (LTCHW)
$0.01
-0.03
+1550%

Top Losers

Last Price
Chg
Chg%
$0.19
-123.15
-99.85%
$0
-0.11
-99.55%
$0
-0
-97.96%
$0
-0.01
-93.94%
$0.01
-0.06
-92.24%

About

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing patient’s diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is headquartered in Parsippany, New Jersey.

Address

300 Kimball Drive, Parsippany, NJ, United States, 07054